Codes / ICD10CM / F19.232

F19.232 Other psychoactive substance dependence with withdrawal with perceptual disturbance

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Other Psychoactive Substance Dependence with Withdrawal with Perceptual Disturbance
  • ICD-10 Code: F19.232

Summary

Other psychoactive substance dependence with withdrawal with perceptual disturbance refers to a pattern of substance use that leads to clinically significant impairment, characterized by a strong desire to use the substance, difficulty controlling use, and continued use despite negative consequences. Withdrawal with perceptual disturbance occurs when substance use is reduced or stopped, resulting in perceptual abnormalities such as hallucinations or distorted sensory experiences. This condition involves substances not classified under more specific categories (e.g., alcohol, opioids, cannabis) and may include dependence on agents like caffeine, nicotine, or other non-specified psychoactive substances.

Causes

The causes of this condition include chronic use of psychoactive substances that alter brain function, psychological factors such as stress or trauma, and social influences like peer pressure. The addictive potential of these substances, combined with repeated use, can lead to dependence over time, resulting in withdrawal symptoms when use is discontinued. Perceptual disturbances may arise due to abrupt cessation or significant reduction in substance use, particularly in individuals with prolonged or heavy use.

Risk Factors

  • Genetic predisposition to addiction
  • Co-occurring mental health disorders (e.g., anxiety, depression)
  • Early exposure to psychoactive substances
  • Environmental factors (e.g., access to substances, social norms)

Symptoms

  • Intense cravings or urges to use the substance
  • Inability to reduce or control use
  • Perceptual disturbances (e.g., hallucinations, distorted sensory experiences)
  • Anxiety or agitation
  • Physical symptoms (e.g., tremors, sweating)

Diagnosis

Diagnosis is based on clinical evaluation, including a detailed history of substance use, withdrawal symptoms, and perceptual disturbances. Healthcare providers assess the pattern of use, duration, and impact on daily functioning. Laboratory tests or imaging may be used to rule out other conditions, but diagnosis primarily relies on clinical criteria and patient history.

Treatment Options

Treatment may include medically supervised withdrawal management to address acute symptoms, followed by behavioral therapies (e.g., cognitive-behavioral therapy) to support long-term recovery. Medications may be used to manage withdrawal symptoms or co-occurring conditions. Supportive care, such as counseling or support groups, is often recommended to address psychological and social factors.

Prognosis and Follow-Up

Prognosis varies depending on the severity of dependence, presence of co-occurring conditions, and adherence to treatment. Regular follow-up is important to monitor for relapse, manage withdrawal symptoms, and adjust treatment as needed. Long-term recovery often requires ongoing support and lifestyle modifications.

Complications

  • Severe withdrawal symptoms (e.g., seizures, delirium)
  • Co-occurring mental health disorders
  • Social or occupational impairment
  • Risk of relapse

Lifestyle & Prevention

  • Avoiding substance use or reducing exposure to psychoactive substances
  • Seeking early intervention for substance use concerns
  • Building healthy coping mechanisms for stress or trauma
  • Engaging in supportive relationships or community resources

When to Seek Professional Help

Seek medical attention if withdrawal symptoms are severe, persistent, or accompanied by perceptual disturbances, or if substance use is interfering with daily life. Immediate care is necessary for symptoms like hallucinations, confusion, or physical distress.

Tips for Medical Coders

Document the presence of perceptual disturbances (e.g., hallucinations, distorted sensory experiences) during withdrawal to support the F19.232 code assignment. Ensure clinical notes specify the substance type (if known) and the duration/severity of withdrawal symptoms. Verify that the condition meets diagnostic criteria for dependence and withdrawal with perceptual disturbance.

Book a walkthrough

F19.232 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.